Inventor

Lawrence M. Kauvar

Inventor

San Francisco, CA, US

Overview

1990–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 75 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

G01Nprimary

G01NInvestigating or analysing materials by determining their chemical or physical properties21%

C07KPeptides19%

A61KPreparations for medical, dental or toiletry purposes13%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%

C12NMicroorganisms or enzymes6%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%

B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%

B01DSeparation3%

Y10TTechnical subjects covered by former us classification2%

PatentTitleYear

11,077,188Drug regimen for treatment of cerebral ischemia2021 11,046,764Native human antibodies for immune checkpoint modulation targets TIM-3 and B7-H32021 10,858,431Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling2020 10,676,520Antibodies useful in passive influenza immunization2020 10,654,915Antibodies useful in passive influenza immunization2020 10,639,370Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof2020 10,617,756Drug regimen for treatment of cerebral ischemia2020 10,570,193Binding moieties for biofilm remediation2020 10,233,234Binding moieties for biofilm remediation2019 10,030,069High affinity human antibodies to human cytomegalovirus (CMV) gB protein2018 9,913,899'Diagnostic marker for treatment of cerebral ischemia'2018 9,688,744'High affinity human antibodies to human cytomegalovirus (CMV) GB protein'2017 9,439,961'Pharmaceutical composition for treating ischemic events'2016 9,321,839'Antibodies immunoreactive with heregulin-coupled HER3'2016 9,321,830'Anti-RSV G protein antibodies'2016 9,017,668'High affinity human antibodies to human cytomegalovirus (CMV) gB protein'2015 8,828,388'Antibodies immunoreactive with heregulin-coupled HER3'2014 8,652,476'Pharmaceutical composition for treating ischemic events'2014 8,568,973'Cell-signaling assays'2013 8,362,215'Antibodies immunoreactive with heregulin-coupled HER3'2013 8,273,354'Anti-RSV G protein antibodies'2012 7,939,344'Use of particulate labels in bioanalyte detection methods'2011 7,736,648'Anti-RSV G protein antibodies'2010 7,504,230'Method of identifying a useful set of signal transduction proteins from a multiplicity of potentially useful proteins'2009 7,413,868'Use of particulate labels in bioanalyte detection methods'2008 RE039866'Nonpeptide insulin receptor agonists'2007 7,238,490'Real time detection of intermolecular interaction'2007 7,060,447'Protein localization assays for toxicity and antidotes thereto'2006 7,029,695'Therapeutic compositions containing glutathione analogs'2006 RE038915'Nonpeptide insulin receptor agonists'2005 6,936,427'Real time detection of intermolecular interaction'2005 6,867,007'Binary or polynary targeting and uses thereof'2005 6,806,053'Cell-signaling assays'2004 6,673,554'Protein localization assays for toxicity and antidotes thereto'2004 6,642,062'Multihued labels'2003 6,492,125'Method to assess library X library interactions'2002 6,444,992'High throughput microscopy'2002 6,329,431'Nonpeptide insulin receptor agonists'2001 6,057,092'Cellular transport detection method'2000 6,054,286'Methods to identify immunomodulators using cognate interaction of PKC-theta'2000 6,013,462'Glutathione analogs as reagents'2000 5,955,432'Metabolic effects of certain glutathione analogs'1999 5,908,919'Urethane mediated, GST specific molecular release systems'1999 5,880,097'Tethered prodrugs'1999 5,851,988'Nonpeptide insulin receptor agonists'1998 5,846,722'System to detect small molecule/peptide interaction'1998 5,830,918'Nonpeptide insulin receptor agonists'1998 5,801,225'Sorbent families'1998 5,798,275'Profiling reference panel enriched by non-IG proteins'1998 5,786,336'Target-selective protocols based on mimics'1998 5,783,405'Rapid screening method for effectors of signal transduction'1998 5,767,086'Bone marrow stimulation by certain glutathione analogs'1998 5,763,570'Glutathione analogs and paralog panels comprising glutathione mimics'1998 5,741,653'Profiling reference panel enriched by non-Ig proteins'1998 5,717,085'Process for preparing codon amidites'1998 5,679,643'Glutathione analogs and paralog panels comprising glutathione mimics'1997 5,674,688'Method for analyte classification by SC profiles'1997 5,620,901'Determination of concentration by affinity titration'1997 5,599,901'Sorbent families'1997 5,599,903'Glutathione analogs and paralog panels comprising glutathione mimics'1997 5,587,293'Method to identify binding partners'1996 5,567,317'Method to identify analyte-binding ligands'1996 5,556,942'Glutathione S-transferase-activated compounds'1996 5,545,621'Glutathione S-transferase-activated compounds'1996 5,541,070'Method to identify and characterize candidate drugs'1996 5,409,611'Method to identify analyte-binding ligands'1995 5,384,263'Method to produce immunodiagnostic reagents'1995 5,356,784'Determination of concentration by affinity titration'1994 5,340,474'Panels of analyte-binding ligands'1994 5,338,659'Method for determining analyte concentration by cross-reactivity profiling'1994 5,300,425'Method to produce immunodiagnostic reagents'1994 5,217,869'Method to produce immunodiagnostic reagents'1993 5,155,049'Blotting technique for membrane assay'1992 5,133,866'Method to identify analyte-bending ligands'1992 4,963,263'Method of identity analyte-binding peptides'1990

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1990–2000Patents assigned to TERRAPIN TECH INC (32)· patent assignee history

1990–2021Based in San Francisco, CA, US· patent location history

1992Based in San Bernardino, CA, US· patent location history

2000–2007Patents assigned to TELIK INC (5)· patent assignee history

2002–2011Patents assigned to TRELLIS BIOSCIENCE INC (9)· patent assignee history

2005–2009Based in Mountain View, CA, US· patent location history

2012–2020Patents assigned to KAUVAR LAWRENCE M (6)· patent assignee history

2013–2021Patents assigned to TRELLIS BIOSCIENCE LLC (13)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
TERRAPIN TECH INC	32	1990–2000
TRELLIS BIOSCIENCE LLC	13	2013–2021
TRELLIS BIOSCIENCE INC	9	2002–2011
KAUVAR LAWRENCE Mself	6	2012–2020
TELIK INC	5	2000–2007

Locations

Location	Patents	Span
San Francisco, California, US	70	1990–2021
Mountain View, California, US	4	2005–2009
San Bernardino, California, US	1	1992